These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34378233)

  • 1. STAT3 maintains skin barrier integrity by modulating SPINK5 and KLK5 expression in keratinocytes.
    Kim J; Kim MG; Jeong SH; Kim HJ; Son SW
    Exp Dermatol; 2022 Feb; 31(2):223-232. PubMed ID: 34378233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome.
    Zingkou E; Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165831. PubMed ID: 32442469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proinflammatory role of KLK6 protease in Netherton syndrome.
    Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
    J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
    J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
    Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
    J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A; Deraison C; Lacroix M; Bonnart C; Robin A; Besson C; Dubus P; Hovnanian A
    J Exp Med; 2009 May; 206(5):1135-47. PubMed ID: 19414552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
    Kasparek P; Ileninova Z; Zbodakova O; Kanchev I; Benada O; Chalupsky K; Brattsand M; Beck IM; Sedlacek R
    PLoS Genet; 2017 Jan; 13(1):e1006566. PubMed ID: 28095415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.
    Ramesh K; Matta SA; Chew FT; Mok YK
    Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
    J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
    Cheong KA; Lee TR; Lee AY
    J Dermatol Sci; 2017 Aug; 87(2):192-200. PubMed ID: 28433430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEKTI domain 6 displays anti-inflammatory action in vitro and in a murine atopic dermatitis model.
    Canbolat P; Wilzopolski J; Kaessmeyer S; Filor V; Vidak J; Rüger M; Mägert HJ; Forssmann WG; Bäumer W
    J Dermatol Sci; 2024 Jul; 115(1):13-20. PubMed ID: 38849289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes.
    Le NA; Katsuyama M; Demura M; Tanii H; Katsuyama H; Saijoh K
    Environ Health Prev Med; 2014 Jul; 19(4):307-13. PubMed ID: 24894987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The skin barrier function gene SPINK5 is associated with challenge-proven IgE-mediated food allergy in infants.
    Ashley SE; Tan HT; Vuillermin P; Dharmage SC; Tang MLK; Koplin J; Gurrin LC; Lowe A; Lodge C; Ponsonby AL; Molloy J; Martin P; Matheson MC; Saffery R; Allen KJ; Ellis JA; Martino D; ;
    Allergy; 2017 Sep; 72(9):1356-1364. PubMed ID: 28213955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 Signature.
    Gouin O; Barbieux C; Leturcq F; Bonnet des Claustres M; Petrova E; Hovnanian A
    J Invest Dermatol; 2020 Jun; 140(6):1184-1194. PubMed ID: 32169475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome.
    Zingkou E; Pampalakis G; Sotiropoulou G
    J Clin Immunol; 2022 Apr; 42(3):597-605. PubMed ID: 35040012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound K improves skin barrier function by increasing SPINK5 expression.
    Park NJ; Bong SK; Lee S; Jung Y; Jegal H; Kim J; Kim SK; Kim YK; Kim SN
    J Ginseng Res; 2020 Nov; 44(6):799-807. PubMed ID: 33192123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.